Ustekınumab Treatment In Leukocyte Adhesıon Defıcıency (Lad) Type 1 Patıents Wıth Typhlıtıs, E-Poster Dıscussıon [The Clinical Working Party of the European Society of Immunodeficiencies Multidisciplinary Symposium on the Immunological Consequences of targeted Immune Therapies